Sponsored by Precision ADVANCE, this Endpoints webinar with convene leading advanced therapy experts to discuss manufacturing strategies for next-generation medicines. This discussion will be moderated by Adam Pfeiffer (VP of Strategy, Project Farma), and include insights from Charlie Harper (VP, Project Farma), Brian Stamper (VP of Cell Therapy Operations, Immunomic Therapeutics Inc.), Jim Watson (VP, Project Farma), Brian Riley (Chief Manufacturing Officer, Beam Therapeutics), and Chad Salisbury (SVP, Project Farma).
Key points to be discussed:
- The current state of markets effect on the manufacturing sector
- Internal vs external manufacturing and determining the right approach
- Flexible manufacturing, phased implementation, CQV, automation, and other strategies to optimize manufacturing for next-gen medicines
- New innovative technologies on the horizon